{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:12:50Z","timestamp":1769605970882,"version":"3.49.0"},"reference-count":51,"publisher":"Practical Medicine Publishing House","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Oncohematology"],"abstract":"<jats:p>Anaplastic large cell lymphoma (ALCL) includes different types of the disease that are heterogeneous according to clinical, morphological, immunological, cytogenetic and molecular biological features. The review demonstrates not only main clinical and morphoimmunological characteristics of ALCL, but also presents data about expression and prognostic significance of STAT3, pSTAT3tyr705, and survivin (transcription factor). It demonstrates the value of defining the minimal disseminated disease (the minimal disseminated disease is evaluated using the PCR test before initiation of the treatment, and the minimal residual disease is evaluated during the treatment and after its completion), and clinical and molecular biological prognostic factors are also identified. There is still no a standard therapeutic regimen for pediatric ALCL patients. However, the following therapeutic protocols are considered most effective: NHL-BFM 90\/95, CCG5941, SFOP-LM 89\/91, UKCCSG, ALCL99-Vinblastine, POG \u0410\u0420\u041e 9315, AIEOP LNH-92\/97. Treatment outcomes are presented in this paper. Particular attention is paid to different molecular biological markers that allow further improvement of patients\u2019 stratification in risk groups and possible use of target medications (multikinase inhibitors and monoclonal antibodies) improving the therapy outcomes.<\/jats:p>","DOI":"10.21320\/2500-2139-2016-9-2-199-207","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T18:18:02Z","timestamp":1467224282000},"page":"199-207","source":"Crossref","is-referenced-by-count":2,"title":["Modern Aspects of Diagnosis and Treatment of Anaplastic Large Cell Lymphoma in Children (Literature Review)","\u0421\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u044b\u0435 \u0430\u0441\u043f\u0435\u043a\u0442\u044b \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0438 \u0438 \u043b\u0435\u0447\u0435\u043d\u0438\u044f \u0430\u043d\u0430\u043f\u043b\u0430\u0441\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u043a\u0440\u0443\u043f\u043d\u043e\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u043e\u0439 \u043b\u0438\u043c\u0444\u043e\u043c\u044b \u0443 \u0434\u0435\u0442\u0435\u0439 (\u043e\u0431\u0437\u043e\u0440 \u043b\u0438\u0442\u0435\u0440\u0430\u0442\u0443\u0440\u044b)"],"prefix":"10.21320","volume":"9","author":[{"given":"Andrei Sergeevich","family":"Levashov","sequence":"first","affiliation":[{"name":"N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u041d.\u041d. \u0411\u043b\u043e\u0445\u0438\u043d\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041a\u0430\u0448\u0438\u0440\u0441\u043a\u043e\u0435 \u0448., \u0434. 24, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 115478"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. T.","family":"Valiev","sequence":"additional","affiliation":[{"name":"N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u041d.\u041d. \u0411\u043b\u043e\u0445\u0438\u043d\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041a\u0430\u0448\u0438\u0440\u0441\u043a\u043e\u0435 \u0448., \u0434. 24, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 115478"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Kovrigina","sequence":"additional","affiliation":[{"name":"Hematology Research Center, 4\u0430 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0413\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041d\u043e\u0432\u044b\u0439 \u0417\u044b\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 4\u0430, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125167"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Popa","sequence":"additional","affiliation":[{"name":"N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u041d.\u041d. \u0411\u043b\u043e\u0445\u0438\u043d\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041a\u0430\u0448\u0438\u0440\u0441\u043a\u043e\u0435 \u0448., \u0434. 24, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 115478"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"Mentkevich","sequence":"additional","affiliation":[{"name":"N.N. Blokhin Russian Cancer Research Center, 24 Kashirskoye sh., Moscow, Russian Federation, 115478"},{"name":"\u0424\u0413\u0411\u0423 \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0438\u043c. \u041d.\u041d. \u0411\u043b\u043e\u0445\u0438\u043d\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u041a\u0430\u0448\u0438\u0440\u0441\u043a\u043e\u0435 \u0448., \u0434. 24, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 115478"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8834","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"key":"17172","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2007.1.285"},{"key":"17173","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V66.4.848.bloodjournal664848"},{"key":"17174","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/345053"},{"key":"17175","unstructured":"Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edition. Lyon: IARC Press; 2008."},{"key":"17176","unstructured":"\u041a\u043e\u0432\u0440\u0438\u0433\u0438\u043d\u0430 \u0410.\u041c., \u041f\u0440\u043e\u0431\u0430\u0442\u043e\u0432\u0430 \u041d.\u0410. \u041b\u0438\u043c\u0444\u043e\u043c\u0430 \u0425\u043e\u0434\u0436\u043a\u0438\u043d\u0430 \u0438 \u043a\u0440\u0443\u043f\u043d\u043e\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u044b\u0435 \u043b\u0438\u043c\u0444\u043e\u043c\u044b. \u041c.: \u041c\u0418\u0410, 2007. \u0421. 212.[Kovrigina AM, Probatova NA. Limfoma Khodzhkina i krupnokletochnye limfomy. (Hodgkin\u2019s lymphoma and large cell lymphomas.) Moscow: MIA Publ.; 2007. pp. 212. (In Russ)]"},{"key":"17177","unstructured":"\u0412\u0430\u043b\u0438\u0435\u0432 \u0422.\u0422., \u041c\u043e\u0440\u043e\u0437\u043e\u0432\u0430 \u041e.\u0412., \u041a\u043e\u0432\u0440\u0438\u0433\u0438\u043d\u0430 \u0410.\u041c. \u0438 \u0434\u0440. \u0414\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0430 \u0438 \u043b\u0435\u0447\u0435\u043d\u0438\u0435 \u0430\u043d\u0430\u043f\u043b\u0430\u0441\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u043a\u0440\u0443\u043f\u043d\u043e\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u044b\u0445 \u043b\u0438\u043c\u0444\u043e\u043c \u0443 \u0434\u0435\u0442\u0435\u0439. \u0413\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u044f \u0438 \u0442\u0440\u0430\u043d\u0441\u0444\u0443\u0437\u0438\u043e\u043b\u043e\u0433\u0438\u044f. 2012;51(1):3\u20139. [Valiev TT, Morozova OV, Kovrigina AM, et al. Diagnosis and treatment of anaplastic large-cell lymphomas in children. Gematologiya i transfuziologiya. 2012;51(1):3\u20139. (In Russ)]"},{"key":"17178","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.5411"},{"key":"17179","doi-asserted-by":"publisher","DOI":"10.1016\/S1578-2190(10)70598-9"},{"key":"17180","unstructured":"Brugieres L, Deley MC, Pacquement H, et al. CD30 Anaplastic Large-Cell Lymphoma in Children: Analysis of 82 Patients Enrolled in Two Consecutive Studies of the French Society of Pediatric Oncology. 1998;92(10):3591\u20138."},{"key":"17181","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03482.x"},{"key":"17182","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.12.3699"},{"key":"17183","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.245"},{"key":"17184","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-100958"},{"key":"17185","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21438"},{"key":"17186","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21817"},{"key":"17187","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.11.075"},{"key":"17188","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24125"},{"key":"17189","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.11-7-831"},{"key":"17190","unstructured":"Delsoll G, Brugieres L, Gaulard P, et al. Anaplastic large cell lymphoma, ALK-positive and anaplastic large cell lymphoma ALK-negative. Hematol Meet Rep. 2009;3(1):51\u20137."},{"key":"17191","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205152"},{"key":"17192","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2008.01.005"},{"key":"17193","unstructured":"Khoury JD, Medeiros LJ, Rassidakis GZ, et al. Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- Anaplastic Large Cell Lymphoma. Clin Cancer Res. 2003;9:3692\u20139."},{"key":"17194","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2009.05.006"},{"key":"17195","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.10.172"},{"key":"17196","doi-asserted-by":"publisher","DOI":"10.1309\/FNY8Y4H6PK1V2MGE"},{"key":"17197","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2011.11.020"},{"key":"17198","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2008.11.012"},{"key":"17199","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07754.x"},{"key":"17200","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-251892"},{"key":"17201","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-066852"},{"key":"17202","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-526202"},{"key":"17203","unstructured":"Jaffe ES. What\u2019s new on the horizon in T-cell lymphoma. [Internet] Available from: http:\/\/www.ercongressi.it\/t-cell-slide\/April%2027,%202015\/01.%20T-cell%20world\/1%20-%20Jaffe.pdf. (accessed 18.04.2016)."},{"key":"17204","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-571091"},{"key":"17205","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22940"},{"key":"17206","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-0973"},{"key":"17207","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.5999"},{"key":"17208","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25187"},{"key":"17209","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.09.021"},{"key":"17210","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.1764"},{"key":"17211","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05910.x"},{"key":"17212","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.8417"},{"key":"17213","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07740.x"},{"key":"17214","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.8972"},{"key":"17215","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.0402"},{"key":"17216","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002965"},{"key":"17217","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70095-0"},{"key":"17218","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt378"},{"key":"17219","unstructured":"National Cancer Insitute. A Randomized Phase II study of Brentuximab Vedotin (NSC# 749710) and Crizotinib (NSC# 749005) in Patients with Newly Diagnosed Anaplastic Large Cell Lymphoma (ALCL) IND #117117. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2016 April 18]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01979536?term=NCT01979536&rank=1. NLM Identifier: NCT01979536."},{"key":"17220","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.33.15_suppl.10058"},{"key":"17221","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.33.15_suppl.10005"},{"key":"17222","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0846"}],"container-title":["Clinical Oncohematology"],"original-title":[],"link":[{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/485\/449","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/485\/449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T11:26:44Z","timestamp":1764502004000},"score":1,"resource":{"primary":{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/view\/485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,4,1]]}},"URL":"https:\/\/doi.org\/10.21320\/2500-2139-2016-9-2-199-207","relation":{},"ISSN":["2500-2139","1997-6933"],"issn-type":[{"value":"2500-2139","type":"electronic"},{"value":"1997-6933","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4,1]]}}}